| 摘要 |
PROBLEM TO BE SOLVED: To provide maintenance of platelet inhibition during antiplatelet therapy.SOLUTION: Ischemic events of patients, and diseases or conditions of patients that were previously treated with at least one thienopyridine, are treated or prevented by administering to the patients an effective amount of at least one reversible, short period-acting P2Yinhibitor (for example cangrelor). The method can be used for patients diagnosed with symptoms such as stable or unstable angina, vascular ischemic events, atherosclerosis, acute coronary syndrome, and STEMI or N-STEMI. The method can also be used for patients that previously received a stent such as a bare metal stent or a drug-eluting stent, and treatment or prevention of stent thrombosis. Further, the method can be used in advance, during, or after coronary artery bypass grafting, percutaneous coronary intervention, or other general invasive surgeries. |
